论文标题
大流行是科学新颖性的催化剂：Covid-19的证据
Pandemics are catalysts of scientific novelty: Evidence from COVID-19
论文作者
论文摘要
科学的新颖性推动了大流行期间发明新疫苗和解决方案的努力。首次合作和国际合作是两个关键渠道，可扩展团队的搜索活动，以解决应对全球挑战所需的更广泛的资源范围，这可能有助于产生新颖的想法。我们对98,981次冠状病毒论文的分析表明，通过Biobert模型衡量的科学新颖性，该模型已在2900万PubMed文章中进行了预培训，而在Covid-19的爆发后，首次合作增加了，国际合作的突然下降。在Covid-19期间，发现具有更多首次合作的论文更为新颖，国际合作并没有像正常时期那样阻碍新颖性。研究结果表明，有必要取得遥远的资源以及在大流行期间维持民族主义以外的协作科学界的重要性。
Scientific novelty drives the efforts to invent new vaccines and solutions during the pandemic. First-time collaboration and international collaboration are two pivotal channels to expand teams' search activities for a broader scope of resources required to address the global challenge, which might facilitate the generation of novel ideas. Our analysis of 98,981 coronavirus papers suggests that scientific novelty measured by the BioBERT model that is pre-trained on 29 million PubMed articles, and first-time collaboration increased after the outbreak of COVID-19, and international collaboration witnessed a sudden decrease. During COVID-19, papers with more first-time collaboration were found to be more novel and international collaboration did not hamper novelty as it had done in the normal periods. The findings suggest the necessity of reaching out for distant resources and the importance of maintaining a collaborative scientific community beyond nationalism during a pandemic.
